Navigation Links
Simmons Firm Announces Settlement of Contingent Fee Antitrust Lawsuit
Date:5/3/2010

EAST ALTON, Ill., May 3 /PRNewswire/ -- Simmons Browder Gianaris Angelides & Barnerd LLC of East Alton, Ill., today announced the resolution of their client Synergetics USA, Inc.'s (Nasdaq: SURG) antitrust lawsuit pending against Alcon Laboratories, Inc., and Alcon, Inc.  Synergetics announced on April 27, 2010, that it had entered into a Settlement and Licensing Agreement and a Supply Agreement with Alcon, pursuant to which all litigation between the companies would be settled and Alcon would receive a license to sell certain Synergetics-patented products.  Alcon will pay Synergetics $32 million in the arrangement. 

A team of lawyers from the Simmons firm represented Synergetics in the antitrust litigation. In a unique approach to commercial litigation, the firm took on the high-risk litigation under a contingency fee arrangement, whereby Synergetics would pay attorneys' fees only as a percentage of any recovery in the case.  Traditionally, commercial litigation is pursued by outside counsel paid at ever-increasing hourly rates.   

"High-end litigation, particularly in a field like antitrust, typically commands exorbitant hourly billing rates for lawyers," said Derek Brandt, the Simmons firm partner who spearheaded the firm's efforts in the case.  "Our willingness to take the case on a contingency basis meant that a relatively small company like Synergetics could pursue a high-stakes litigation against an infinitely larger competitor. We shared the risk with our client and reached a very gratifying result." 
'/>"/>

SOURCE Simmons Browder Gianaris Angelides & Barnerd LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Simmons Firms Partner Trent Miracle Chosen to Help Lead National Litigation Against Bayer
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... SAN DIEGO , Aug. 31, 2015 ... announced today development of a novel means of ... nucleic acid, RGBP-248, to liver tumors utilizing a ... in development overcomes previous hurdles with gene silencing ... to be delivered throughout the whole body.  By ...
(Date:8/31/2015)... VIEW, Calif. , Aug. 31, 2015   ... the life sciences team at Google announced today that ... people with type 1 and type 2 diabetes. The ... Google,s expertise in analytics, miniaturized electronics and low power ... diabetes care by developing new tools that bring together ...
(Date:8/31/2015)... 2015  Qualcomm Incorporated (NASDAQ: QCOM ) ... Inc., is collaborating with Davita Healthcare Partners ... powered by Qualcomm Life,s 2net™ Device Connectivity Platform ... care, informed interventions and better management of at-risk ... annual Connect 2015 ecosystem conference taking ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... Mass., Jan. 17, 2012  CardioFocus, Inc., developer of ... treatment of atrial fibrillation (AF), announces that a ... Electrophysiology demonstrates the high acute and chronic ... procedure using HeartLight EAS. The study was conducted ...
... Inc. (NYSE Amex: PTN ) announced today ... of non-dilutive funding through the New Jersey Economic Development ... New Jersey net operating losses and research and development ... Palatin Technologies received approximately $637,000 under this program. ...
Cached Medicine Technology:Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 2Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 3Journal of Cardiovascular Electrophysiology Study Shows Promising Single Ablation Procedure Outcomes With HeartLight EAS for Treatment of Atrial Fibrillation 4
(Date:8/31/2015)... Chicago, IL (PRWEB) , ... August 31, 2015 ... ... Gynecologic Cancer Awareness Month 2015 in September by sharing the facts about the ... focused on BRCA1 and BRCA2 genetic mutations because of Angelina Jolie Pitt’s decisions ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Move over ... products for men and barbershops are scrambling to meet it. , Reports published this ... for hairstyles and haircare. But the data also reflects that men are getting more ...
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a social well-being ... walking app, Walkadoo , by including an in-app step tracker. , Walkadoo is ... person’s walking habits. Rather than broadly assign every Walkadoo member 10,000 steps a day ...
(Date:8/31/2015)... ... August 31, 2015 , ... Juvent Sports ( http://www.juvent.com ) ... major sports figures who are finding joint pain relief after using their revolutionary Micro-Impact ... tennis player in the world said, “For the first time in over 20 years ...
(Date:8/31/2015)... ... August 31, 2015 , ... According to book reviewer Angie Santangeloon ... Your Life with Cancer is an excellent resource for everyone since one in ... to be helpful in explaining what cancer is in a easy to understand medically ...
Breaking Medicine News(10 mins):Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 2Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 3Health News:Foundation for Women’s Cancer Alerts Women to the Facts About the Role of Heredity in Gynecologic Cancers 4Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 2Health News:MENAJI Anti-Aging Eraser a New Sure-Fire Add-On Product for Barbershops 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:New Book The Cancer Solution Is a Must Read for Everyone Affected by Cancer 2
... per 1,000 males in the 0-6 age group - has ... Foundation//, to tackle the practice of female foeticide. ... by the Foundation in collaboration with the United Nations Population ... statewide campaign to make people aware of the long-term repercussions ...
... Center in New York say they have identified four genes that ... genes work together. ,Turning off all four genes at ... or metastasise - a study in mice showed. ... planning clinical trials of drugs known to target two of the ...
... patients with untreated sleep apnea are more likely to die than ... ,The study followed 164 patients with heart failure for more than ... had double the death rate of those patients who did not ... death rate was 24% in contrast to 12% for the 113 ...
... Fertility declining among men of north India. And thanks to tight ... of Medical Sciences// (AIIMS), New Delhi. ,A ten-year study ... fertility, reports say. ,The sperm count of a normal ... ml as against 60 million per ml around 30 years ago. ...
... Reports by the Centers for Disease Control and Prevention say there ... Americans//, with a body mass index of 40 or more. ... increased by 50 percent from 2000 to 2005(twice as fast as ... an increase by 24 percent of overweight people (BMI of ...
... the use of insect cells appeared safe and produced ... promises to be an alternative to using embryonated eggs ... preliminary study. ,"All currently licensed influenza ... hen's eggs. There are several well-recognized disadvantages to the ...
Cached Medicine News:Health News:Genes That Spread Breast Cancer Fast Identified 2Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 2Health News:Sleep Disorder Linked to Heart Failure Patient Deaths 3Health News:Denim Lovers Beware, Fertility Could Be in Danger, Says a New Study 2Health News:Experimental Flu Vaccine Appears Promising in Early Tests 2
... The MFERG is available in conjunction ... the UTAS-E3000mf or EPIC-4000 or as a ... MFERG visual electrodiagnostic test uses a software ... monitor to stimulate many areas of the ...
... LKCs Sweep VEP technology is designed for productivity ... in conjunction with doctors from the University of ... over a decade on over 5,000 subjects. All ... be set and stored, or can be preset ...
... the exact enhanced corneal thickness measuring algorithm ... exclusively by the OHTS investigators. The IOP ... The new backlit LCD character displays OD ... and IOP correction calculation and allows easy ...
The Medmont C100 Colour Vision Tester is an electronic colour vision screening device which is used to rapidly detect red/green colour vision deficiencies. Its high sensitivity provides a positive in...
Medicine Products: